look at charts folks.
Seeking Alpha 2/6/14
While some companies have begun to test agents in this class, Celldex's CDX-1127 appears to be the leading candidate, which is already being tested with other agents. In early preclinical testing, CDX-1127 and a CD3 antibody induced cancer killing Th1-like signals from T cell cytokine responses. Furthermore, in
co-stimulating CD3 and CD27 Celldex produced a near eight-fold production of T cells at its high dose of 10mcg/ml.
By: Brian Nichols
Combination Therapies: Where Immuno-Oncology Is Headed And How To Invest
Feb. 6, 2014 8:55 AM E
By Zacks Equity Research
A team sent by Tesla Motors, Inc. (TSLA-Free Report) has completed the journey from Los Angeles to New York, setting a record for the lowest charge time for an electric vehicle traveling across the country. The team traveled in two Tesla Model S cars and relied solely on Tesla’s Supercharger network during the cross-country drive. As a result, the team incurred zero fuel cost.
Tesla’s Superchargers not only provide free charging to Model S owners, but also charge faster than normal electric charging stations. They can restore half the battery charge in just 20 minutes, while normal charging stations take as much as 9 hours for a full charge.
Tesla currently has over 70 Superchargers in North America and is expanding the network fast. The company recently also completed the feat of having at least one car registered in all 50 states of the U.S.
In a separate news, Tesla will soon open its first store in Contra Costa County, according to Contra Costa
Zack's Carries A 1# Strong Buy Rating on Telsa
January 31,2014 - The Fly On The Wall
Article Facebook price target raised to $80 from $62 at JPMorgan
JPMorgan raised its price target for Facebook shares to $80 citing the company's strong ad revenue growthand solid user engagement trends in Q4. The firm says Facebook remains one of its favorite ideas and keeps an Overweight rating on the stock